BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies

导出原文传递

翻译打印收藏纠错

作者： Poh, Weijie ^[1] ; Dilley, Robert L. ^[2] ; Moliterno, Alison R. ^[3] ; Maciejewski, Jaroslaw P. ^[4] ; Pratz, Keith W. ; McDevitt, Michael A. ; Herman, James G.

作者单位： Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Hematol Malignancy, Baltimore, MD USA ^[1] Johns Hopkins Sch Med, Grad Program Pathobiol, Baltimore, MD USA ^[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA ^[3] Cleveland Clin, Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44106 USA ^[4]

发布时间 2019-09-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Clinical cancer research

2019年25卷8期

2513-2522页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除